The new report by Expert Market Research titled, India Pet Grooming Products Market Size, Share, Price, Trends, Growth, Report and Forecast 2021-2026, gives an in-depth analysis of theIndia pet grooming products market, assessing the market based on its segments like applications, manufacturing process and major regions. The report tracks the latest trends in the industry and studies their impact on the overall market. It also assesses the market dynamics, covering the key demand and price indicators, along with analyzing the market based on the SWOT and Porters Five Forces models.

Get a Free Sample Report with Table of Contents https://bityl.co/CasR

The key highlights of the report include:

Market Overview (2016-2026)

Forecast CAGR (2021-2026): 13%

Indias pet care market is expected to grow during the forecast period, owing to the growth of nuclear families, dual-income households, lifestyle choices, urbanization, and increased pet ownership. Delayed parenthood, which is prevalent among urban and newlywed couples, has boosted the countrys pet adoption rate, transforming it into an emotional stimulant. Dog care products are the markets largest segment, accounting for more than half of the market share. Consumer awareness about pet health and well-being is propelling Indias pet grooming products industry. The market is also benefiting from the growing popularity of cats and rabbits as pets. Additional factors, such as the growing number of manufacturers, innovations, and specialized products, are expected to significantly propel the markets growth. The growing presence of veterinary clinics and pet stores is also expected to contribute to the markets growth. Over the forecast period, rising disposable incomes and the growing concept of pet parenting amongst todays generation are expected to drive the market growth.

Industry Definition and Major Segments

Pet grooming is defined as the care and maintenance of pets. Grooming is necessary to maintain the pets health.

Read Full Report with Table of Contents https://bityl.co/CasO

By types, the market is divided into:

Shampoos and Conditioners Combs and Brushes Clippers and Scissors Others

By distribution channel, the market is divided into:

Hypermarkets and Supermarkets Pet Stores Veterinary Clinics Online Others

By region, the industry is categorized into:

North India South India East India West India

Market Trends

Most pet care products are distributed through veterinary clinics. In terms, of distribution channels, veterinary clinics account for the largest share in the market. The sectors growth has been aided by an increase in per-pet spending and increased pet ownership. Additionally, the countrys growing number of dog grooming salons is expected to increase demand for pet grooming products. Meanwhile, Indias increasing preference for online shopping is expected to accelerate the growth of the online sector. This will contribute significantly to the market growth over the forecast period.

Shampoos and conditioners make up a huge part of the market share. This is because the number of cases of hair loss, skin diseases, and other ailments is increasing amongst pets. Cats and dogs are the most popular pets, both of which have furs. As a result, they require extensive cleansing, conditioning, and deodorization. These factors are expected to contribute to the growth of the market during the forecast period.

Key Market Players

The major players in the market are Glenand Group of Companies, Petkin Inc., Petacom, Wahl Clipper Corporation, Terrai Natural Products, Scoobee Pet Products, among Others. The report covers the market shares, capacities, expansions, investments and mergers and acquisitions, among other latest developments of these market players.

About Us:

Expert Market Research is a leading business intelligence firm, providing custom and syndicated market reports along with consultancy services for our clients. We serve a wide client base ranging from Fortune 1000 companies to small and medium enterprises. Our reports cover over 100 industries across established and emerging markets researched by our skilled analysts who track the latest economic, demographic, trade and market data globally.

At Expert Market Research, we tailor our approach according to our clients needs and preferences, providing them with valuable, actionable and up-to-date insights into the market, thus, helping them realize their optimum growth potential. We offer market intelligence across a range of industry verticals which include Pharmaceuticals, Food and Beverage, Technology, Retail, Chemical and Materials, Energy and Mining, Packaging and Agriculture.

Media Contact

Company Name: Claight CorporationContact Person: Mathew Williams, Business ConsultantEmail:sales@expertmarketresearch.comToll Free Number: US +1-415-325-5166 | UK +44-702-402-5790Address: 30 North Gould Street, Sheridan, WY 82801, USAWebsite: https://www.expertmarketresearch.com

Read More Reports:

Motor Graders Market:https://www.digitaljournal.com/pr/global-motor-graders-market-to-be-driven-at-a-cagr-of-5-in-the-forecast-period-of-2021-2026

Stem Cell Banking Market:https://www.digitaljournal.com/pr/global-stem-cell-banking-market-to-be-driven-at-a-cagr-of-13-5-in-the-forecast-period-of-2021-2026

Virtual Reality Market:https://www.digitaljournal.com/pr/global-virtual-reality-market-to-be-driven-by-rising-demand-for-virtual-platforms-in-the-forecast-period-of-2021-2026-3

Smart Ticketing Market:https://www.digitaljournal.com/pr/global-smart-ticketing-market-to-be-driven-by-the-rapid-technological-advancements-in-the-forecast-period-of-2021-2026

Automotive Vacuum Pump Market:https://www.digitaljournal.com/pr/global-automotive-vacuum-pump-market-to-be-driven-by-demand-from-the-automotive-pump-market-in-the-forecast-period-of-2021-2026

Also, CheckProcurement Intelligencewhich provides you Infallible research solutions.

*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.

Read the original:
India Pet Grooming Products Market To Be Driven By Rising Disposable Income And The Growing Concept Of Pet Parenting During Forecast Period Of...

New York, June 27, 2022 (GLOBE NEWSWIRE) -- The global animal stem cell therapy market recorded sales of around US$ 249.9 Mn in 2021 and the market is predicted to experience healthy growth over the years ahead at a CAGR of 5.2% (2022 to 2032).

Animal stem cell therapies are treatments for disorders such as arthritis, soft tissue injuries, traumatic fractures, tendonitis, inflammatory bowel disease, and others that are given to animals. Hematopoietic stem cells and mesenchymal stem cells are used in these treatment procedures.

As the focus on giving animals a better quality of life grows, so does the adoption of such therapies across the world. The market for animal stem cell therapy is predicted to continuously increase owing to the growing need for higher levels of veterinary care.

Request for sample copy of report: https://www.persistencemarketresearch.com/samples/14941

Regulatory bodies are also encouraging veterinary regenerative medicine research & development.

The European Commission has approved a few stem cell-based products within the region.

The animal stem cell therapy market is moderately fragmented with a few key market players and presents numerous opportunities for new market entrants to create a foothold in the industry. Increased pet adoption rate can be a beneficial factor for manufacturers of stem cells to expand into emerging markets.

Know the methodology of report: https://www.persistencemarketresearch.com/methodology/14941

Key Takeaways from Market Study

Get customized report as per requirement: https://www.persistencemarketresearch.com/request-customization/14941

With rising disposable incomes and higher adoption rate of pet animals, the global market for animal stem cell therapy is set to gain traction over the coming years, says an analyst of Persistence Market Research.

Market Competition

Key animal stem cell therapy providers are investing in innovating veterinary regenerative medicines and they are also coming up with new product launches for the well-being of animals.

Along with product innovation, market players are also aiming for various collaborations to strengthen their R&D in the field of animal stem cell therapy.

Get full access of report: https://www.persistencemarketresearch.com/checkout/14941

What Does the Report Cover?

Persistence Market Research offers a unique perspective and actionable insights on the animal stem cell therapy market in its latest study, presenting historical demand assessment of 2012 2021 and projections for 2022 2032.

The research study is based on product type (hemopoietic stem cells and mesenchymal stem cells), source (allogeneic and autologous), indication (osteoarthritis, soft tissue injuries, traumatic fractures, tendonitis, inflammatory bowel disease, and others), species (canine, feline, and equine), and end user (veterinary hospitals, veterinary clinics, and veterinary research institutes), across seven key regions of the world.

Other Trending Reports:

About Persistence Market Research:

Business intelligence is the foundation of every business model employed by Persistence Market Research. Multi-dimensional sources are being put to work, which include big data, customer experience analytics, and real-time data collection. Thus, working on micros by Persistence Market Research helps companies overcome their macro business challenges.

Persistence Market Research is always way ahead of its time. In other words, it tables market solutions by stepping into the companies/clients shoes much before they themselves have a sneak pick into the market. The pro-active approach followed by experts at Persistence Market Research helps companies/clients lay their hands on techno-commercial insights beforehand, so that the subsequent course of action could be simplified on their part.

Contact

Rajendra Singh

Persistence Market Research U.S. Sales Office:305 Broadway, 7th FloorNew York City, NY 10007+1-646-568-7751United StatesUSA - Canada Toll-Free: 800-961-0353Email: sales@persistencemarketresearch.com

Visit Our Website:https://www.persistencemarketresearch.com

See the article here:
Animal Stem Cell Therapy Market projected CAGR of 5.2% for the next ten years (2022-2032) Persistence Market Research - GlobeNewswire

The biotechs all new neurorestorative approach aims to rebuild and replace lost brain cells in Alzheimers that underlies clinical symptoms.

On the back of the trial, the company plans to launch a world-first human trial in 2024.

The veterinary trial, led by Skin2Neuron and published this month in Stem Cell Research and Therapy, reversed the dementia-like syndrome that strikes down many older pet dogs with Alzheimers.

Dementia was reversed in more than half of the canine patients, with a clinically meaningful improvement in 80%. Typically, improvement lasted around two years.

Skin2Neuron champions its new approach as a ray of hope for Alzheimers disease: championing a completely different approach to the amyloid hypothesis of Alzheimers disease.

Our target is the ultimate cause of dementia: lost neurons and synapses. We do this by microinjecting a patients own HFN cells directly into the hippocampus, the brains memory center and first area to be devastated by Alzheimers, explains the company.

While its lead therapeutic target is Alzheimers, it says its technology also has potential to treat neurodegenerative conditions such as Parkinsons disease, Amyotrophic Lateral Sclerosis and more.

A dogs thinking neocortex and hippocampus is similar to the human brain, says the company. Meanwhile, older dogs often develop a dementia syndrome similar to human dementia: becoming forgetful, irritable, lost, wandering around aimlessly, failing to recognize owners and experiencing disrupted sleep.

"Because of deep parallels between the canine brain and human brain, and canine Alzheimer's and human Alzheimer's, I started this trial 10 years ago with the assumption that if it's going to work in humans, then it needs to work in dogs first. And the results exceeded my wildest expectations, said co-founder Professor Michael Valenzuela.

"The hippocampus, the memory center of the brain, was packed with baby neurons and new synapses, precisely where we delivered the cells. Compared to untreated dogs, it was like night and day".

Microscopic analysis confirmed the dogs had classic Alzheimer pathology: meaning the cell therapy worked in the setting of natural disease, a first of its kind, according to the company.

"Given our doggie patients also had many of the same health issues that older people face, it gives me even greater confidence," said Valenzuela.

Study:Valenzuela, M., Duncan, T., Abey, A.et al.Autologous skin-derived neural precursor cell therapy reverses canine Alzheimer dementia-like syndrome in a proof of concept veterinary trial.Stem Cell Res Ther13,261 (2022). https://doi.org/10.1186/s13287-022-02933-w

Read the rest here:
'A new Alzheimer's treatment is on the horizon': Cell therapy reverses dementia-like syndrome in dogs - BioPharma-Reporter.com

His plight tugged at the heartstrings of dog lovers all over the country when rescuers discovered an abandoned puppy who was suffering from almost 100 gun shot wounds

The dog was just about six months old when he was reported as a stray to Friends of Rescue in Derry and the charity volunteers were horrified to discover his coat was hiding severe injuries and starvation. They called him Darragh and started him on the road to recovery.

And today, almost two months on the Belgian shepherd has made a remarkable recovery is ready to find his forever home.

Read more: Could you manage your dog at your workplace?

A spokesperson for the charity said: "Our handsome Darragh is now fully recovered and ready to find his own family.

"Darragh was found cowering at the side of the road at only six months old unable to move. When we got him to safety we realised he was covered in wounds but under his heavy coat it was difficult to see.

"We had to shave him right down and then it was discovered that Darragh had been shot. There were more than 90 pellets in his body that we could clearly see in his X-ray and he has had a few surgeries since to remove the ones that could be safely reached.

"He was emaciated when he arrived, weighing just 12.8kg, but now weighing a fabulous 24kg he is looking so well - in fact he is well enough that he has been signed off by our vet as a healthy boy, so he is ready for adoption."

The team say Darragh is understandably shy and nervous about meeting new people and facing new experiences, but he comes round with patience and understanding as he has with his foster family.

And his new family will need to work with him to allow him to blossom at his own pace and work on his confidence with gentle reassurance and guidance

A spokesperson said: "Once he's comfortable you will see he is an absolute sweetheart and an absolute eejit. He loves curling up on the sofa when he's not trying to play with a toy or lick you to get a pet.

"Many people mistake Darragh for a Dutch shepherd because of his shorter hair, but he had been shaved and now its slowly growing back. Darragh is actually a Belgian shepherd so he will have long flowing hair and be stunning.

He doesnt like being alone, although crate trained he likes to know youre there, so no long working hours

He can live with cats

He will need a few meetings with any dog in the home

No kids under 10

Suzanne Fleming from the charity said: "His recovery is incredible and he is such a lovely boy. Darragh deserves a fantastic forever loving home and we hope to secure that for him as soon as possible. In the meantime he is in foster care where he is treated as family and loved 100%.

"Sadly he is not the only dog who needs out help and we are working at full capacity with vet bills mounting and the stream of animals in need of urgent care increasing daily.

"But while we continue to pick up after other peoples possessions we will always have to ask for help, so we hope you hear our plea. We simply cannot keep taking in any more animals without getting our vets bills down."

Darragh was found near stables close to Lenamore Rd, Co Derry. He was taken to a foster home for triage where his wounds were examined and then on to VetsForPets in Crescent Link, Derry, where he had about 90 lead pellets removed from his body, including 50 from around his neck.

Darragh's treatment and rehabilitation, feeding and medical costs were added to the most recent list of animals in need at Friends of rescue.

And dogs like Darragh need long term care, fostering and then a search for the right home to adopt him with costs rising daily.

Suzanne said: "Rescuing animals is heart breaking and it doesn't get easier. This poor pup was found lying alone near a stables in Co Derry, he had been left to die. Darragh didn't deserve this, no animal does. But he had no voice and so it's up to rescues like us to set in to protect the vulnerable, the ones who need us most and Darragh is the prime example of why we do what we do."

Darragh was discovered by a man who was out hacking on his horse, who spotted the dark bundle in the undergrowth and discovered it was a young dog who was lying motionless.

He called the Friends of Rescue for help and they discovered the dog had suffered around 100 injuries from lead pellet blasts.

Darragh's timeline

Suzanne said: We would also like to say a massive thank to everyone who has helped in any way towards Darragh's medical treatment, recovery and rehabilitation and to @filo for Darraghs Box of Love. To say he loved it was an understatement.

"Darragh is just one of the animals who has had extensive treatment in his time with us, and we cant continue our work without the generosity of the public.

If you would like to help Friends of rescue as they continue to help abused, abandoned and neglected animals, you can donate to them via Vets4Pets Crescent Link in person or via phone on 02871314420 or visit the charity's Paypal account by clicking here.

Read next:

Read the original here:
Shot with 90 pellets and abandoned, but today Derry dog Darragh is ready for loving home - Belfast Live

What can you say about dogs? There may not be enough words to describe the love they can bring into your home. Dogs can be your best friend and sometimes your only friend. They are there through all of your breakups and makeups and they love you unconditionally. Dogs are truly a member of the family.

What would you do if a member of your family went missing for days? Your son, daughter, brother, sister or your pup wandered off and was now gone? A New York State pooch did just that and you won't believe where he ended up.

According to the New York State Police, a 13 and a half year old Golden Retriever named Lilah disappeared recently in the town of Conklin. Lilah had been missing for several days and, as you could imagine, her owners were worried sick.

One day a call come in to New York State Police dispatch regarding a dog stuck in a culvert pipe, which is a drainage pipe that typically runs underground, perhaps under a roadway, driveway or train tracks. Could this be Lilah?

Photo by Crawford Passy on Unsplash

New York State Trooper "Jimmy Rasaphone out of Binghamton responded to the call with Trooper Ana Reynas to assess the scene. Turns out this dog was now pretty deep underground so the officers needed to act quickly. Trooper Rasaphone tied a rope to a dog leash and crawled into the dark pipe.

The Trooper eventually reached the dog and was able to attach the collar t the pooch and lead her out of the pipe and yes, it was Lilah! As you can see if the picture below, Lilah could use a bath but she has safely been returned to her owners. Nice work officers!

New York State Police

Does your loyal pup's breed make the list? Read on to see if you'll be bragging to the neighbors about your dog's intellectual prowess the next time you take your fur baby out for a walk. Don't worry: Even if your dog's breed doesn't land on the list, that doesn't mean he's not a good boy--some traits simply can't be measured.

To prepare yourself for a potential incident, always keep your vet's phone number handy, along with an after-hours clinic you can call in an emergency. The ASPCA Animal Poison Control Center also has a hotline you can call at (888) 426-4435 for advice.

Even with all of these resources, however, the best cure for food poisoning is preventing it in the first place. To give you an idea of what human foods can be dangerous, Stacker has put together a slideshow of 30 common foods to avoid. Take a look to see if there are any that surprise you.

New York's official state dog, which was adopted in 2015, isn't a specific breed, but rather an occupation according to the law,

"The working dog shall be the official dog of the

state.For the purposes of this section, 'working dog' shall mean (see specific professions below):"

See original here:
NY State Trooper Tries to Save Dog Stuck In Pipe! How'd She Get There? - Q105.7

Global Viral Inactivation Market from 2022 to 2028 contains a detailed analysis of the current market status, market player, region, type, and application. The report provides an in-depth assessment of growth factors, market definition, manufacturers, market potential, and influencing trends to understand future demand and outlook for the global industry. The report presents an analysis of market size, share, and growth, trends, cost structure, statistical and comprehensive data of the global Viral Inactivation market. The report gives a clear picture of the current market situation. It includes historical and technological factors and valuates market size in terms of value and volume, in the market.

This research report represents an overview of the competitive landscape of the global Viral Inactivation market. Furthermore, it offers massive data relating to recent trends, technological advancements, tools, and methodologies. The research report collects data about the target market such as pricing trends, customer requirements, competitor analysis, and other such details.

Request For a Sample Report: https://www.marketquest.biz/sample-request/75260

Some of the companies competing in the market are:

The report covers size, share, and forecast (value and volume) by regions, top players, product types, and applications, with historical data along with a forecast from 2022 to 2028. . The report offers in-depth insights, revenue details, and other vital information regarding the global Viral Inactivation market and the various trends, drivers, restraints, opportunities, and threats in the target market.

Product type segmentation of the market:

Application segmentation of the market:

By region of the market:

Browse Complete Report: https://www.marketquest.biz/report/75260/global-viral-inactivation-market-2021-by-company-regions-type-and-application-forecast-to-2026

The report then displays a review of the effect of recent developments in the global Viral Inactivation market on the markets future development prospects. A thorough analysis of statistics about the current as well as emerging trends offers clarity regarding the market dynamics.

The Report Answers Questions Such As:

Customization of the Report:

This report can be customized to meet the clients requirements. Please connect with our sales team ([emailprotected]), who will ensure that you get a report that suits your needs. You can also get in touch with our executives on +1-201-465-4211 to share your research requirements.

Contact UsMark StoneHead of Business DevelopmentPhone: +1-201-465-4211Email: [emailprotected]Web: http://www.marketquest.biz

You May Check Our Other Report @

Global Continuous Vacuum Filters Market 2022 Worldwide Overview by Industry Size, Future Trends, Growth Factors and Leading Players by 2028

Global Hypertension Drug Market 2022 Future Trends, SWOT Analysis, Remarkable Growth, and Competitive Landscape by 2028

Global Infectious Immunology Market 2022 Size, Share, Applications, Advance Technology and Top Companies to 2028

Global Foam Coatings Market Competitive Strategy Analysis and Forecast Values (2022-2028)

Global Telescoping Boom Lifts Market 2022 Size, Share, Applications, Advance Technology and Top Companies to 2028

Global Bias Heavy-Duty Tires Market 2022 Future Developments, Key Vendors, Regional Analysis, and Industry Scope by 2028

Global Nano Titanium Dioxide Market Competitive Strategy Analysis and Forecast Values (2022-2028)

Global Knuckleboom Loaders Market 2022: Top Countries Data, Trending Technologies, Key Players and Geographical Regions by 2028

Global Virtual Reality Content Creation Market Competitive Strategy Analysis and Forecast Values (2022-2028)

Global Home Security System Market Competitive Landscape and Analysis by Recent Trends 2022 to 2028

Here is the original post:
Global Viral Inactivation Market 2021 Growth Opportunities and Competitive Landscape 2027 Danaher, Merck, Parker Hannifin, Sartorius Indian Defence...

Anita Kumar, MD, medical oncologist with Memorial Sloan Kettering Cancer Center, led a session at the 2022 Annual Meeting of the American Society of Clinical Oncology (ASCO), on New Directions in Mantle Cell Lymphoma.

In the United States, about 4000 people per year are diagnosed with mantle cell lymphoma (MCL), a cancer that develops from malignant B-lymphocytes in an area of the lymph node known as the mantle zone.1

As Anita Kumar, MD, a medical oncologist with Memorial Sloan Kettering Cancer Center explained to lead off a session at the 2022 Annual Meeting of the American Society of Clinical Oncology (ASCO), MCL is associated with chronic activation of the B-cell receptor complex. This, she said, has allowed for the development of Bruton tyrosine kinase (BTK) inhibitors, such as ibrutinib, as well as PI3 kinase inhibitors.

Many factors guide decisions on initial treatment after diagnosis, such as the patients age, fitness, and especially transplant eligibility. In recent years, the chemoimmunotherapy combination of bendamustine and rituximab has become the standard of care for patients who are not eligible for autologous stem cell transplant (ASCT).

However, mantle cell lymphoma is both clinically and biologically heterogeneous, Kumar said. And this really challenges the one-size-fits-all approach using chemoimmunotherapy across the board. We know this from our clinical practice.

Kumars talk on approaches for treatment-nave MCL anchored the ASCO session she chaired, New Directions for Mantle Cell Lymphoma in 2022. The June 6 session also featured talks by Toby Eyre, MBChB, MRCP, consultant hematologist at the Department of Hematology, University of Oxford, who discussed prognostic markers in MCL; and Chan Cheah, clinical professor of medicine, University of Western Australia. Cheah focused on novel therapies in relapsed/refractory settings, including the use of chimeric antigen receptor (CAR) T-cell therapy and bispecific antibodies to treat MCL.

Eyre offered an overview of current risk stratification of MCL patients, which highlighted the importance of the TP53 mutation as an extremely strong predictor of inferior overall survival (OS) in trials across several new therapeutic classes. Clinical factors can be useful, but not at the expense of testing for TP53 mutations, he said.

The use of the MCL International Prognositic Index (MIPI), combined with a measure of proliferation of the Ki-67 protein allows clinicians to group MCL patients into one of 4 risk categories for diagnostic, treatment, and clinical trial purposes, he said.

Kumar followed with a case for stratification, as she discussed the range of conditions among newly diagnosed MCL patients. There are patients with non-nodal leukemic MCL whose disease is indolent; often, these patients can be monitored for years. And on the other end of the spectrum, we see blastoid mantle cell lymphoma that's highly aggressive with high proliferation; oftentimes with evidence of chemoresistance and inferior survival, she said.

Investigators are learning more about the biology of these different presentations, Kumar said. More conventional MCL is associated with greater genomic instability and TP53 mutation, along with inferior OS. In addition, minimal residual disease assessment has allowed for novel treatment paradigms to be explored in mantle cell lymphoma, she said, as she reviewed studies that linked MRD status to remission duration. MRD, she said, has the potential as a surrogate end point, as a marker to predict relapse during surveillance or therapeutic resistance, and to potentially help doctors decide when treatment can cease or less treatment is needed.

A case in point: in the Cooperative Group Study EA4151, newly diagnosed transplant eligible patients are randomized after induction therapy to ASCT with rituximab maintenance or just rituximab.2 This is an exciting clinical trial design, because it leverages MRD assessment as a prognostic biomarker, and potentially in patients who achieve a deep molecular remission investigates whether we can omit upfront autologous stem cell transplant, she said.

As with other types of lymphoma, theres discussion whether to move newer targeted therapies and other non-chemotherapy treatments into earlier lines of treatment, where they might be more effective with fewer toxic effects. Kumar outlined this discussion in light of results from the SHINE trial, presented earlier at ASCO, which showed adding ibrutinib to bendamustine and rituximab offered a progression-free survival (PFS) benefit but no OS benefit.3

She said the Triangle study will examine 870 younger, fitter patients examine 3 arms: one with alternating regimens of well-known chemotherapy combinations followed by ASCT, one with ibrutinib added to one of the chemotherapy combinations followed by ASCT, and one with the chemotherapy combinations and ibrutinib only.4 Again, Kumar said, the trial may demonstrate an ability to achieve better outcomes without ASCT.

Chemotherapy-free combinations, including those that include BTK inhibitors, are a major area of study. Kumar reviewed these findings:

Concern about the cardiovascular effects of ibrutinib has led to trials with zanubrutinib, a second-generation BTK inhibitor. A 500-patient, phase 3 clinical trial of 2 different regimens of zanubrutinib with bendamustine vs zanubrutinib alone is under way.6

Triplet combinations are now being studied in MCL. Kumar reviewed the results for OASIS, which studied ibrutinib, obinutuzumab, and venetoclax in 15 mostly low-to-intermediate MIPI patients, of whom 2 had a TP53 mutation.7 The idea here is to leverage dual BTK and BCL2 inhibition, which is known to be synergistic in MCL, Kumar said. The PET complete response (CR) at 6 months was 86.6%; after a median follow-up of 14 months, 1-year PFS was 93%.

This establishes this triplet combination as a highly active treatment program in mantle cell lymphoma, and it was also demonstrated that this was well tolerated, she said. Of great interest, we see that this combination was active in patients who had a TP53 mutation as well as blastoid disease.

Kumar concluded with 2 other trials of interest to payers:

We really recommend enrollment in a clinical trial for patients who have a TP53 mutation, Kumar said. Insights into mantle cell lymphoma disease biology have improved our biologic risk stratification, and certainly identification of a TP53 mutation at time of initial diagnosis is of great importance.

References

See the rest here:
Challenging the One-Size-Fits-All Approach in Early MCL Treatment - AJMC.com Managed Markets Network

BRIGHTON A major expansion at the Oxford Recovery Center promises to offer children with autismsafe and controlled experiences in "real-world" situations.

Officials with the organization sayThe Village of ORC at the Oxford Recovery Center, the first such center in the United States,isdesigned to bring therapy and hands-on experience together for those who struggle with person-to-person interactions.

Founder and CEOTami Peterson said the objective is to create real-world scenarios for children and young adults so they will know how to behave when confronted withsimilar circumstances in everyday life.

"We created the real world environment the best we could," Peterson said."Kids with autism deserve the best and we really do believe that and practice that."

Peterson saidchildren with autism don't interpret the difference between real and fakesituations well, so it'sdifficult for them to pretend.

The organization hosted agrand opening on Saturday, June 11at 7030 Whitmore Lake Road.The $12-million, 35,000-square-foot building took more than a year to complete.

"I'll get emotional. I was in awe to be able to move into this building. I literally never thought we would use it. God says he always makes things more immeasurably beyond our belief. I say I dream small, God dreams big," Peterson said. "He gave me the vision. I never believed that this was planned. I get to watch people get their lives back every day and God chose me to do this. Clearly he does not choose people who are equipped he equips those he chooses."

The Village of ORC includes 12 functioning "retail stores," as well as a park featuring a road, curbs, sidewalks, benches, street lamps, stoplights, cross walks and an indoor playscape.

The 12 storesincludea grocery store, smoothie station, toy jungle, village caf, coffee house, pet store, Dino Dentistry, gift shop, a Huntington Bank ATM andhair salon. All proceedsgo towardthe Oxford Kids Foundation.

The retail stores are open to the public, and operated by people fromthe Creating Opportunities Maximizing Potential Achieving Successful Skillsprogram. According to Peterson, COMPASSis a six-month programfor young adults who have a degree or a diploma, are diagnosed with autismand are seeking employment.

Those adults enterthe program because theyare having trouble keeping jobsbecause of autism-associated behaviors. According to Peterson, only 8% of young adults with autism have meaningful employment. The COMPASS program allows individuals to self assess and work on goals.

"We can contrive scenarios in our different stores as they are spending time working in those stores," Peterson said.

Children in the Autism Recovery Through Synergy programparticipating in ABA therapy, such as speech, occupational and physical therapy, can work on their daily goals, too.

Goalsmay include such things asstanding in line at a grocery store,learning how to order their own food or getting their teeth cleaned at the dentist.

The stores can be used to practice executive functioning skills, intrapersonal skills and the opportunity to problem solve real world scenarios, according to Peterson.

Thepark provides a wayto teach children how to behavein a park, as well aswhat to do on a sidewalk or in a cross walk.

Other aspects of the expansion include a commercial kitchen where a trained chef will prepare lunches, multipletreatment rooms,a water room, and an art and music room.

The water room can help clients become desensitized to common sensory aversions like getting their hair or face wet. It can also simulate a thunderstorm to get clients comfortable with the sounds that come from storms.

In addition to treatment for autism-related issues, ORC offers physical, occupational and speech therapy, as well as, hyperbaric oxygen therapy, neurofeedback therapy and medical lab testing. They provide treatment for issues related to cerebral palsy, traumatic brain injury, stroke, Parkinson's and other conditions.

Peterson founded the center in 2008 after her daughter, JeAnnah Powell, responded well tohyperbaric oxygen therapy after contracting viral encephalitis in 2006 when she was 9.

The center was first located in 1,800-square-foot space in South Lyon. Additionally, they have a locationin Troy. The ORClater expanded into a 24,000-square-foot facility in Brighton in 2018.

Xander Salsitz, who performed as a saxophonist at the grand opening, has been a client and said he's benefited from the center.

In January 2012, at 8 years old, Salsitz was diagnosed with myelodysplastic syndrome, afull deletion of chromosome 7 in the bone marrow stem cell, which quickly led to complete bone marrow failure.

After two failed transplants, his family stumbled onto the hyperbaric oxygen therapy in South Lyon.

"We're very grateful and I did (hyperbaric oxygen treatments)over 760 times, I probably wouldn't be standing here today if it wasn't for Tami," he said.

Salsitz is set to bea freshman at the University of Michigan in the fall, where he will seeka bachelor's degree in music theory, focusing on jazz and contemporary improvisation.

ContactLivingston Daily reporterPatricia Alvord at palvord@livingstondaily.com about news coverage.

Here is the original post:
Oxford Recovery Center in Brighton reveals $12M expansion - Daily Press & Argus

This is the time of the year when most of us head outdoors for some sunshine and fresh air but did you know a poisonous plant is spreading across Arkansas like wildfire that is so toxic if you come in contact it could land you in the hospital or even kill you.

The flowering plant is known as hemlock one of the most poisonous plants in the world, according to the United States Department of Agriculture and it has been seen growing all over the state. You may often see these white flower pedal flowers growing in your backyard, nearby wooded areas, or along a fence line but don't let these flowers deceive you they are very toxic to humans and pets. For example, you could be cutting some bushes or brush around the house, or field, even brush against it on a hike and that could lead to some very serious health complications such as heart arrhythmias and could even slow down your heart rate, according to medical experts.

Other symptoms include nausea, vomiting, convulsions, trembling, and in some cases muscle paralysis all of which could land you in the ER if not taken seriously. The alkaloids could trigger impulse transmission to your muscles leading to respiratory failure and killing you. It doesn't take long for the toxins to take effect, normally around 10 minutes or longer.

If you think you have come in contact with hemlock, call your doctor or medical professional immediately.

Poison hemlock belongs to the same plant family as carrots, parsnips, fennel, and dill. The plant can grow from 2-to 10 feet tall and the entire plant is poisonous.

Poison Hemlock also has a dark past as mentioned in this video.

To prepare yourself for a potential incident, always keep your vet's phone number handy, along with an after-hours clinic you can call in an emergency. The ASPCA Animal Poison Control Center also has a hotline you can call at (888) 426-4435 for advice.

Even with all of these resources, however, the best cure for food poisoning is preventing it in the first place. To give you an idea of what human foods can be dangerous, Stacker has put together a slideshow of 30 common foods to avoid. Take a look to see if there are any that surprise you.

Read more:
Poison Plant Spreading in Arkansas That Could Kill You - kkyr.com

From heart transplants to implantable devices, BHF-funded science has helped to develop innovations that once seems like science fiction. Heres a preview of what the future of medicine might bring next.

Around one in every 200 newborn babies has a heart problem that needs surgery or another procedure. Professor John Simpson and his team at Evelina London Childrens Hospital and Kings College London are using a BHF grant to work on a virtual reality technology to improve these procedures.

He explains: We look at detailed scan images of an individuals heart in order to decide what is the right procedure, at the right time, with the minimum risk.

In the last couple of decades, weve gone from 2D to 3D images. But youre still looking at them on a flat screen. Even 3D printed models of hearts are not perfect you have to break it to see the structures inside. Also, the 3D models show the heart at one moment in time. But the living heart is dynamic; it beats, and the valves open and close.

With his teams new technology, information from heart scans routinely taken in hospitals can be turned into a virtual, beating heart. With the headset on, and joystick in your hand, the virtual heart is right in front of you. You can zoom in and out, see it from every angle and look inside, says Dr Natasha Stephenson, Professor Simpsons fellow researcher.

In a previous study, surgeons used the technology to review operations that had already taken place. They found that, compared to traditional 3D imaging, it gave them a better understanding of the patients heart and would have helped them better plan the surgeries. Now the team are working towards testing this technology to plan real procedures, which they hope to do in the next two years.

This technology allows surgeons to understand what theyll actually face in the operation, says Professor Simpson. You can put a virtual device into the virtual heart and see which will be the best device. Or even share the imaging with companies that can make bespoke devices to fit the individuals heart. We hope this will mean better repairs, fewer complications, shorter hospital stays and better long-term outcomes.

These virtual reality images can also be used to show patients what the issues are with their heart, or used to train doctors.

While Professor Simpsons focus is on congenital heart diseases, he says, In the long term, this technology could also help better visualise the problems of adults with other types of heart disease.

Sign up to our fortnightly Heart Matters newsletter to receive healthy recipes, new activity ideas, and expert tips for managing your health. Joining is free and takes two minutes.

After a heart attack, some heart muscle cells can die off, which can lead to heart failure. Dr Nicola Smart is trying to answer questions that might one day help us to help hearts regrow themselves.

From studies in mice, we know a couple of days after birth, the heart can fully regenerate. A week after birth, it loses that ability, explains Dr Smart.

To repair itself, the heart needs to grow new blood vessels, as well as new muscle. In adults, there is some growth of blood vessels, but it happens slowly and inefficiently.

She and her team at the University of Oxford are studying how different types of cells in different parts of the heart send signals to each other, helping the heart to grow new blood vessels. Through a technique called single-cell RNA-sequencing, she is seeing which of the genes involved in this process are switched off (not expressed) in adults.

Single-cell RNA-sequencing has completely changed our level of understanding. It used to be that we could only look at overall gene expression changes in a heart. That could tell you nothing about how different cells were responding to a heart attack. Now we see which genes are being expressed in each cell, we know even the same types of cells will respond differently in different parts of the heart.

Dr Smart says were just at the start of understanding how this new knowledge might lead to treatments in future. Regrowing heart muscle and blood vessels is only one part. Other teams are looking at how to limit scarring and how to work with the immune system, which also influences the hearts ability to regenerate. But if we can bring together all these ideas, we could develop a combination therapy to stimulate the heart to regenerate, and that could prevent more people developing heart failure.

Scarring is part of the bodys healing process. But it can cause problems. After a heart attack, too much scarring can stop the heart working well and cause heart failure.

MRI scansare currently used to look at scars that have already formed in peoples hearts. Now BHF-funded research is developing a cutting-edge technique so doctors can track scarring as it happens.

Professor Marc Dweck and his team at the University of Edinburgh are using PET scanning, a type of very detailed scan that can show how your bodys cells are working. Were using a new tracer a special chemical, which attaches to cells that cause scarring. The tracer sends a signal that we can detect on the scan.

Right now, we dont have a clear idea of when scarring occurs following a heart attack. In people who develop heart failure, do they have too much scarring activity or is it that scarring doesnt turn off at the right time?

His team will try to find the answers by studying people whove recently had heart attacks, as well as people who have old scarring from previous heart attacks, and healthy people.

Understanding how scarring develops may help us predict who will make a good recovery after a heart attack and who will need more treatment to prevent heart failure, explains Professor Dweck. Were talking precision medicine: with better scanning, we can tailor the right treatment to the right patient.

Pulmonary arterial hypertension (PAH) is a rare but serious condition, which causes high blood pressure in the arteries of the lungs. It can lead to heart failure and can sometimes be fatal. Currently there is no cure. BHF-funded researcher Alex Ainscough, at Imperial College London, is developing a new way to look for treatments.

He's created a pulmonary artery on a chip, in which the innermost layers of the artery walls are recreated inside a silicone rubber microchip just 1mm wide (the same size as the small arteries that are first affected in PAH).

In traditional research, you look at one type of cell, but in our bodies different cell types interact with each other, explains Dr Ainscough. We are trying to make it as representative of the human body as possible.

By running liquid through the chip, he can mimic the flow of blood in the body, which has a big impact on the cells. He explains: When you grow cells in a petri dish for research, its like theyre in the calm of a lake; but in the body, they are being subjected to forces like a fast-flowing stream.

He created a model of a diseased artery by using stem cells from people with PAH to create a pulmonary artery on a chip, which led to him discovering a previously unknown way in which PAH develops.

As well as being used as an investigative tool to understand how PAH happens, the pulmonary artery on a chip is being used to try out potential treatments. Dr Ainscough is working with a pharmaceutical company to test some of their existing drugs, as well as new drugs that are in development to treat PAH.

He predicts that in future, organ-on-a-chip models will help make treatments cheaper and quicker to develop. These models more closely match conditions in people compared to traditional petri dish research, so it will be faster to identify promising drugs before moving to clinical trials.

Theres also potential to use these for more personalised medicine. You could use stem cells from a particular person to create a microchip model to see how theyll react to a specific drug before giving it to them.

Most babies having surgery for heart defects will need repairs using additional materials such as patches, valves or tubes. These products are either made from animal tissue or synthetic material: they wont grow with the child and will become scar tissue and gradually deteriorate.

Massimo Caputo, BHF Professor of Congenital Heart Surgery at the University of Bristol, explains: This means a child might need surgery weeks after theyre born, again after a year or two, then after another five years, and carry on having repeated surgeries all their lives.

Each surgery can cause more scarring, which can cause problems like heart failureor abnormal heart rhythms. Theres also the mental stress of going through these operations. For years, patients and parents have said to me, Why cant we have a valve that lasts forever?

Thanks to one of our research grants, Professor Caputo is developing a kind of living tissue, made partly from stem cells, that will grow with the child. Hes currently in the process of securing regulatory approval and the first tests in patients should start in two to three years.

This living tissue could reduce the need for multiple surgeries, in adults as well as children. If you have a valve replacement from animal tissue, this will wear down and you will need to replace it after 10 years. Even if youre in your 50s or 60s, that could mean multiple surgeries. The tissue Im working on could be applied to adult surgery too, says Professor Caputo.

Another benefit is that this tissue could be less likely to be rejected by the body: A patients own stem cells could be used to produce the tissue, so that the immune system recognises it and doesnt reject it.

Published 10 June 2022

Continued here:
From sci-fi to reality: a peek into the future of medicine - British Heart Foundation